Acer Therapeutics Statistics Share Statistics Acer Therapeutics has 0
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding n/a Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 18.37M Failed to Deliver (FTD) Shares 41,270 FTD / Avg. Volume 1.73%
Short Selling Information The latest short interest is 121.87K, so 0% of the outstanding
shares have been sold short.
Short Interest 121.87K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -1.51 and the forward
PE ratio is null.
Acer Therapeutics's PEG ratio is
-0.02.
PE Ratio -1.51 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio -2.36 P/FCF Ratio -1.3 PEG Ratio -0.02
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Acer Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.19,
with a Debt / Equity ratio of -0.71.
Current Ratio 0.19 Quick Ratio 0.19 Debt / Equity -0.71 Debt / EBITDA -0.48 Debt / FCF -0.39 Interest Coverage -242.67
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-874.57K Employee Count 30 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 1.62M Effective Tax Rate -6.19%
Stock Price Statistics The stock price has increased by -0.02% in the
last 52 weeks. The beta is 0.44, so Acer Therapeutics's
price volatility has been higher than the market average.
Beta 0.44 52-Week Price Change -0.02% 50-Day Moving Average 0.81 200-Day Moving Average 1 Relative Strength Index (RSI) 30.16 Average Volume (20 Days) 2,387,245
Income Statement
Revenue n/a Gross Profit n/a Operating Income -24.61M Net Income -26.24M EBITDA -24.55M EBIT -26.14M Earnings Per Share (EPS) -1.77
Full Income Statement Balance Sheet The company has 2.33M in cash and 11.86M in
debt, giving a net cash position of -9.54M.
Cash & Cash Equivalents 2.33M Total Debt 11.86M Net Cash -9.54M Retained Earnings -140.75M Total Assets 14M Working Capital -55.53M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -30.25M
and capital expenditures -171.17K, giving a free cash flow of -30.42M.
Operating Cash Flow -30.25M Capital Expenditures -171.17K Free Cash Flow -30.42M FCF Per Share -1.93
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields ACER does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for ACER.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Sep 21, 2017. It was a
backward
split with a ratio of 12:125.
Last Split Date Sep 21, 2017 Split Type backward Split Ratio 12:125
Scores Altman Z-Score -29.87 Piotroski F-Score 4
